ヘリコバクター・ピロリ診断薬市場：技術別、エンドユーザー別-2025-2030年の世界予測

ヘリコバクター・ピロリ診断薬市場は、2023年に7億5,281万米ドルと評価され、2024年には8億2,228万米ドルに達すると予測され、CAGR 9.71％で成長し、2030年には14億4,046万米ドルに達すると予測されています。

ヘリコバクター・ピロリ（H.ピロリ）診断薬市場は、消化性潰瘍や胃がんに関与することで悪名高いピロリ菌による感染症の検出と管理に焦点を当てた、消化器病学において極めて重要な市場です。この市場には、呼気検査、便検査、血液検査のような非侵襲的手法から、生検を伴う内視鏡検査やPCR検査のような侵襲的手法まで、様々な診断方法が含まれます。正確なピロリ菌診断の必要性は、ピロリ菌が消化器疾患に大きく関与していることに起因しており、治療効果を最適化し合併症を予防するためには、早期かつ正確な検出が必要です。診断薬は、病院、診断検査室、診療所などあらゆる場所で応用されており、個別化医療に向けた世界の推進力を背景に、ポイント・オブ・ケア検査が重視されるようになっています。市場の成長を後押ししているのは、有病率の増加、診断精度の技術的進歩、消化管の健康に対する一般市民の意識の高まりです。しかし、高度な診断ツールの高コスト、一貫性のない償還政策、潜在的な抗生物質耐性などの課題が、市場拡大の妨げとなっています。主な成長機会は、特にヘルスケアへのアクセスが限られている新興国市場において、迅速でコスト効率の高いスクリーニング技術の開発に存在します。自動診断プラットフォームや予測診断のための人工知能の統合に関する研究開発への投資は、画期的な進歩をもたらす可能性があります。企業はヘルスケアプロバイダーとの提携に注力し、遠隔診断に活用するための遠隔医療技術に投資することが推奨されます。規制上のハードルや未発達地域における認知度の低さといった制約はあるもの、この市場は、特に非侵襲的検査ソリューション、AI主導の分析ツール、バリュー・ベース・ケアをサポートする統合ヘルスケア・ネットワークにおいて、有利なイノベーションの道を提示しています。真に卓越するためには、企業は包括的な市場浸透と持続的な成長を確保するために、医療専門家によるピロリ菌検査プロトコルの普及を目指したトレーニングプログラムを優先すべきです。

市場力学：急速に進化するヘリコバクター・ピロリ診断薬市場の主要市場インサイトを公開

ヘリコバクター・ピロリ診断薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 感染症の流行増加
  • ヘリコバクター・ピロリ菌に対する認識の高まり
  • 症状の早期発見に対する需要の高まり
• 市場抑制要因
  • 政府による厳しい規制基準
• 市場機会
  • 個別化抗生物質療法のニーズの高まり
  • 診断薬の技術進歩の急増
• 市場の課題
  • 競争の激しい市場による競合価格圧力

ポーターの5つの力：ヘリコバクター・ピロリ診断薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ヘリコバクター・ピロリ診断薬市場における外部からの影響の把握

外部マクロ環境要因は、ヘリコバクター・ピロリ診断薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヘリコバクター・ピロリ診断薬市場における競合情勢の把握

ヘリコバクター・ピロリ診断薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヘリコバクター・ピロリ診断薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヘリコバクター・ピロリ診断薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ヘリコバクター・ピロリ診断薬市場における成功への道筋を描く

ヘリコバクター・ピロリ診断薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症の蔓延の増加
    • ヘリコバクター・ピロリ菌に対する意識の高まり
    • 症状の早期発見の需要増加
  • 抑制要因
    • 政府による厳格な規制基準
  • 機会
    • 個別化抗生物質療法の必要性の高まり
    • 診断製品の技術進歩の急増
  • 課題
    • 競争の激しい市場による価格競争の圧力
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ヘリコバクター・ピロリ診断薬市場：技術別

• 免疫測定
• 分子診断
• 有価証券

第7章 ヘリコバクター・ピロリ診断薬市場：エンドユーザー別

• クリニック
• 診断研究所
• 病院

第8章 南北アメリカのヘリコバクター・ピロリ診断薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域のヘリコバクター・ピロリ診断薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのヘリコバクター・ピロリ診断薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Alpha Laboratories Ltd.
• Bio-Rad Laboratories, Inc
• Biohit Oyj
• CerTest BIOTEC
• Coris BioConcept SPRL
• Diasorin S.P.A.
• EKF Diagnostics Holdings PLC
• Epitope Diagnostics, Inc.
• Medline Industries, LP
• Meridian Bioscience, Inc.
• Quest Diagnostics Incorporated
• Quidel Corporation
• Sekisui Diagnostics, LLC
• TechLab, Inc.
• Thermo Fisher Scientific Holdings, Inc.

LIST OF FIGURES

• FIGURE 1. HELICOBACTER PYLORI DIAGNOSTICS MARKET RESEARCH PROCESS
• FIGURE 2. HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. HELICOBACTER PYLORI DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. HELICOBACTER PYLORI DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. HELICOBACTER PYLORI DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. HELICOBACTER PYLORI DIAGNOSTICS MARKET DYNAMICS
• TABLE 7. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY POC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY DIAGNOSTICS LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 22. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 23. CANADA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. CHINA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 36. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 37. INDIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 72. ITALY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. POLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 80. POLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. QATAR HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. QATAR HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM HELICOBACTER PYLORI DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. HELICOBACTER PYLORI DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. HELICOBACTER PYLORI DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

The Helicobacter Pylori Diagnostics Market was valued at USD 752.81 million in 2023, expected to reach USD 822.28 million in 2024, and is projected to grow at a CAGR of 9.71%, to USD 1,440.46 million by 2030.

The Helicobacter Pylori (H. pylori) diagnostics market is pivotal in gastroenterology, focusing on the detection and management of infections caused by H. pylori bacteria, infamous for its role in peptic ulcers and gastric cancers. This market encompasses a variety of diagnostic modalities, including non-invasive techniques like breath, stool, and blood tests, as well as invasive methods such as endoscopy with biopsy and PCR tests. The necessity of accurate H. pylori diagnostics stems from the bacterium's significant contribution to gastrointestinal diseases, necessitating early and precise detection to optimize treatment efficacy and prevent complications. Diagnostics find applications across hospitals, diagnostic laboratories, and clinics, with a growing emphasis on point-of-care testing given the global push towards personalized medicine. Market growth is fuelled by increasing prevalence rates, technological advancements in diagnostic accuracy, and rising public awareness about gastrointestinal health. However, challenges such as the high cost of advanced diagnostic tools, inconsistent reimbursement policies, and potential antibiotic resistance hinder its expansion. Key growth opportunities exist in the development of rapid, cost-effective screening techniques, particularly in emerging markets where access to healthcare can be limited. Investment in R&D on automated diagnostic platforms and integration of artificial intelligence for predictive diagnostics offers potential breakthroughs. Companies are recommended to focus on partnerships with healthcare providers and invest in telemedicine technologies to tap into remote diagnostics. Despite limitations such as regulatory hurdles and low awareness in underdeveloped regions, the market presents lucrative innovation avenues, particularly in non-invasive testing solutions, AI-driven analytical tools, and integrated healthcare networks that support value-based care. To truly excel, businesses should prioritize training programs aimed at increasing the uptake of H. pylori testing protocols among healthcare professionals to ensure comprehensive market penetration and sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Helicobacter Pylori Diagnostics Market

The Helicobacter Pylori Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of infectious diseases
  • Increasing awareness of helicobacter pylori
  • Rise in demand early detection of symptoms
• Market Restraints
  • Stringent regulatory norms by government
• Market Opportunities
  • Emerging need for personalized antibiotic therapy
  • Surging technological advancement in diagnostics products
• Market Challenges
  • Competitive pricing pressure due to highly competitive market

Porter's Five Forces: A Strategic Tool for Navigating the Helicobacter Pylori Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Helicobacter Pylori Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Helicobacter Pylori Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Helicobacter Pylori Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Helicobacter Pylori Diagnostics Market

A detailed market share analysis in the Helicobacter Pylori Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Helicobacter Pylori Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Helicobacter Pylori Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Helicobacter Pylori Diagnostics Market

A strategic analysis of the Helicobacter Pylori Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Helicobacter Pylori Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alpha Laboratories Ltd., Bio-Rad Laboratories, Inc, Biohit Oyj, CerTest BIOTEC, Coris BioConcept SPRL, Diasorin S.P.A., EKF Diagnostics Holdings PLC, Epitope Diagnostics, Inc., Medline Industries, LP, Meridian Bioscience, Inc., Quest Diagnostics Incorporated, Quidel Corporation, Sekisui Diagnostics, LLC, TechLab, Inc., and Thermo Fisher Scientific Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Helicobacter Pylori Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Immunoassays, Molecular Diagnostics, and POC.
• Based on End User, market is studied across Clinics, Diagnostics Laboratories, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of infectious diseases
    • 5.1.1.2. Increasing awareness of helicobacter pylori
    • 5.1.1.3. Rise in demand early detection of symptoms
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent regulatory norms by government
  • 5.1.3. Opportunities
    • 5.1.3.1. Emerging need for personalized antibiotic therapy
    • 5.1.3.2. Surging technological advancement in diagnostics products
  • 5.1.4. Challenges
    • 5.1.4.1. Competitive pricing pressure due to highly competitive market
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Helicobacter Pylori Diagnostics Market, by Technology

• 6.1. Introduction
• 6.2. Immunoassays
• 6.3. Molecular Diagnostics
• 6.4. POC

7. Helicobacter Pylori Diagnostics Market, by End User

• 7.1. Introduction
• 7.2. Clinics
• 7.3. Diagnostics Laboratories
• 7.4. Hospitals

8. Americas Helicobacter Pylori Diagnostics Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Helicobacter Pylori Diagnostics Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Helicobacter Pylori Diagnostics Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Alpha Laboratories Ltd.
• 3. Bio-Rad Laboratories, Inc
• 4. Biohit Oyj
• 5. CerTest BIOTEC
• 6. Coris BioConcept SPRL
• 7. Diasorin S.P.A.
• 8. EKF Diagnostics Holdings PLC
• 9. Epitope Diagnostics, Inc.
• 10. Medline Industries, LP
• 11. Meridian Bioscience, Inc.
• 12. Quest Diagnostics Incorporated
• 13. Quidel Corporation
• 14. Sekisui Diagnostics, LLC
• 15. TechLab, Inc.
• 16. Thermo Fisher Scientific Holdings, Inc.